PCLO.X
Recent Headlines
- PharmaCielo Announces Shipment of CBD Full Spectrum Oil to a Brazilian Pharmaceutical Customer
- PharmaCielo Announces Financial Results for the First Quarter Ended March 31, 2022
- PharmaCielo Enters Spanish Market with Initial Shipment of 300 kg of CBD Full Spectrum Oil to Pharmaceutical Company
- PharmaCielo Provides Update on Non-Brokered Private Placement of Debenture Units
- PharmaCielo partners with Soteria Holdings Limited to license, import and wholesale its medical cannabis flower and extracts in the Polish market
- PharmaCielo Announces Financial Results for the Fourth Quarter and Fiscal Year Ended December 31, 2021
- Colombian Government Provides Final Commercial Guidelines Related to the Export of Dried Flower
- PharmaCielo Provides Update on Non-Brokered Private Placement of Debenture Units
- /R E P E A T -- Colombian Government Passes Regulation to Enable Dried Flower Export and Expand Industrial Applications for CBD-Based Products/
- Colombian Government Passes Regulation to Enable Dried Flower Export and Expand Industrial Applications for CBD-Based Products
- PharmaCielo Signs Sales Agreement with Greenstein to Supply THC Final Products that will be Commercialized through NOWEDA, a Pharmaceutical Wholesaler to all Pharmacies Across Germany
- PharmaCielo Provides Update on Latin American Sales Progress and Non-Brokered Private Placement of Debenture Units
- PharmaCielo (CVE:PCLO) investors are sitting on a loss of 49% if they invested a year ago
- PharmaCielo Completes Initial Tranche of Non-Brokered Private Placement of Debenture Units
- PharmaCielo Announces $15.0 Million Non-Brokered Private Placement of Debenture Units
- PharmaCielo Announces Q3-2021 Financial Results
- PharmaCielo Ltd.'s (CVE:PCLO) Shift From Loss To Profit
- PharmaCielo Receives Confirmation of Colombian Phytotherapeutics GMP Certification
- PharmaCielo Announces the Appointment of Cannabis Industry Veterans Bob DeGabrielle and Will Nicholas to the Company's Board
- PharmaCielo Announces Q2-2021 Financial Results and Appointment of Bill Petron as CEO
- PharmaCielo Signs Sales Agreement and Makes Initial Commercial Sale to Pharmaceutical Player in Brazil
- PharmaCielo Welcomes Colombian Government's New Cannabis Decree
- Is PharmaCielo (CVE:PCLO) A Risky Investment?
- PharmaCielo to Participate in the Cantor Fitzgerald International Cannabis Forum
- PharmaCielo Makes Initial Shipment to Canadian Life Sciences Company
- PharmaCielo Announces Election of Directors - Welcomes Bill Petron, a Global Operations and Cannabis Veteran, as Chairman of the Board
- PharmaCielo Announces Financial Results for the First Quarter Ended March 31, 2021
- PharmaCielo Appoints Experienced Cannabis Executive Ian D. Atacan as Chief Financial Officer
- The PharmaCielo (CVE:PCLO) Share Price Is Up 80% And Shareholders Are Holding On
- PharmaCielo Announces Bill Petron, a Global Operations and Cannabis Veteran, to Stand for Election as a Nominee for Chairman of the Board
- PharmaCielo Provides Update on Global GMP Compliance Process
- PharmaCielo Announces Financial Results for the Fourth Quarter and Fiscal Year Ended December 31, 2020
- PharmaCielo Makes Initial Shipments to two Brazilian Customers
- PharmaCielo Announces Closing of Overnight Marketed Equity Offering for Gross Proceeds of $13.5 Million
- PharmaCielo Provides Corporate Update
- IIROC Trading Resumption - PCLO.WT
- Mexico Votes to Advance Recreational Cannabis Legalization - PharmaCielo Mexico Positioned to Become a Preferred Supplier
- IIROC Trading Resumption - PCLO
- PharmaCielo Ltd. Announces Upsize and Pricing of Overnight Marketed Equity Offering
- IIROC Trading Halt - PCLO
- PharmaCielo Ltd. Announces Overnight Marketed Equity Financing
- PharmaCielo Delivers First Commercial Shipment of THC-Free Broad-Spectrum Distillate
- PharmaCielo Provides Update on GMP Compliance Process
- PharmaCielo Announces Appointment of Caroline Lenardon for Expansion of Retail Investor Relations Capacity
- PharmaCielo Enters Strategic Alliance to Provide Pre-Tested and Insured Product to Customers in the U.S. Market
- PharmaCielo Receives Approximately CDN$3.0 Million in Non-Dilutive Funding from Colombian State-Owned Banco Agrario
- PharmaCielo Welcomes Landmark United Nations Decision to Remove Cannabis from Narcotic Drugs List
- PharmaCielo Announces Grant of Stock Options
- PharmaCielo Ltd.'s (CVE:PCLO) Path To Profitability
- PharmaCielo Ltd. Announces New Leadership